Within the past week Moderna has lost nearly $7 billion in valuation after Pfizer stated that things with Covid are slowing down &/or nearly coming to an end with the need for new vaccines.
Compared to the “stay at home stocks” such as Peloton, SnapChat, and others Moderna is still trading at a significantly higher price than its late 2019 trading price.
This makes me think MRNA will continue to fall. Looking at their medicine pipeline, the biggest contributors to their revenue are Covid vaccines. Yes, they have other things in the pipeline, but they’re mostly in Phase 1.
https://www.modernatx.com/research/product-pipeline?
Anybody else have any thoughts on this?
Disclaimer: Poor physician in training. Only have a single MRNA $85p for 11/17
Leave a Reply